Abuse-deterrent opioid analgesic

0 marketed 2 in Phase 3

This page covers all Abuse-deterrent opioid analgesic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu opioid receptor (with opioid antagonist component).

Targets

Mu opioid receptor (with opioid antagonist component)

Phase 3 pipeline (2)